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Differential amyloid precursor protein (APP) gene expression wag investigated ~r. primary cultures of astrocytes, neurons and microglia from 
neonatal rat cerebral cortex as well as in meninges, and young and adult cerebral cortex tissues in order to define the possible contribution of 
individual CNS cell types in flAP deposition. Meninges and neurons contained higher levels of total APP mRNA than glial cells and APP6gs mRNA 
was abundant in neurons while glial ceils and meninges contained higher levels of KPI-containing mRNAs. These results demonstrate c ll-specific 
transcriptional nd post-transcriptional regulation of APP gene expression i  CNS cell types. In addition, the steady-state level of APPs ha each 
cell type did not reflect mRNA levels indicating translational or post-translational regulation. 
APP gcne expression: Central nervous ystem; Microglia; Astrocyte; Neuron 
1. INTRODUCTION 
The amyloid eposits of Alzheimer's disease (AD) 
contain a 3.9--4.2 kDa peptide, the B-amyloid peptide 
(flAP) [1-3] which is a cleavage product of the amyloid 
precursor proteins (APPs). Alternative splicing of the 
APP transcript gives rise to various proteins (APP56~, 
APPTI4, APPv.~I, APPly0), all of which contain a sequence 
homologous to the Kunitz protease inhibitor (KPI) with 
the exception of APP,95. Three of them, APP695, APP751, 
and APP770, are highly but differentially expressed in 
most cells [4-11] whereas APP563 and APPT~4 are ex- 
pressed at lower levels [10-12]. 
flAP deposition in cortical senile plaques of AD has 
been proposed to arise from aberrant proteolytic pro- 
cessing of APP [13,14]. The invariable presence of flAP 
deposits in older patients with Down's syndrome [15,16] 
and the presence of higher levels of APP mRNA in 
Down's brains [7] suggest that over-expression f APP 
may lead to flAP formation. If over-expression f APP 
leads to flAP deposition, it is imperative to characterize 
APP gene expression i  individual cell types of the CNS. 
High levels of APP mRNA and protein detected by in 
situ hybridization and immunocytochemistry suggest 
that flAP in the parenchymal myloid deposits origina- 
tes in neurons [17-24]. The close association of micro. 
glial cells with senile plaques has led to the hypothesis 
that microglia re the producers and processors offlAP 
[25,26] although it has also been suggested that amyloid 
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deposition precedes microglial involvement [27-29]. 
Astrocytes, which appear in high numbers and in close 
proximity to senile plaques [30,31] and have been shown 
to have elevated levels of APP expression in lesioned 
brains [32] could also play a role in flAP deposition. In 
addition, the presence ofamyloid in leptomeningeal and 
cortical vessels uggests vascular tissues may contribute 
to the formation of flAP [33,34]. 
It is known that APP69s mRNA is predominantly 
expressed in the brain whereas KPI-containing APP 
mRNAs are more abundant in peripheral tissues 
[I 0,1 1,35,36]. Quantitative analysis of APP gene expres- 
sion has so far been done on whole tissues [I 1,37-39] or 
regions of the brain enriched in specific cell types [10]. 
In cultures, APP gene expression assessed qualitatively 
by S I nuclease analysis of mouse microglia, astrocytes 
and neurons, has revealed predominant expression of 
APP695 mRNA in neurons and KPI-containing APP 
mRNAs in glial cells [39]. Rat type I astrocytes have 
been reported to contain only non-KPI containing 
forms of APP [40]. Yet, precise information on the regu- 
lation ofAPP gene expression i individual cell types of 
the CNS, as well as accurate quantitation of their rela- 
tive levels of expression, is still needed in order to eval- 
uate their possible contribution to,BAP deposition. 
In this study, we have quantitated ifferential APP 
gene expression in rat cerebral cortex, meninges and 
primary cultures of cortical neurons, astrocytes and mi- 
croglia by Northern blots, slot blots, ribonuclease pro- 
tection assay (RPA) and immunoblots. Primary cell cul- 
tures offer advantages in evaluating APP gene expres- 
sion since the homogeneity of the cell populauon can be 
assessed and levels of total as well as individual APP 
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transcripts can be reliably determined. The rat cerebral 
cortex was used as it conveniently provides a sufficient 
number of cells to pursue these experiments. Regulation 
of APP gene expression in the rat is likely to be closely 
related to that of the human since there is 97% homol- 
ogy in their cDNAs [17]. In addition, the human APP 
promoter is active in rat PCI2 cells [41] and shows 
neuron specific expression in a transgenic mouse [42]. 
Therefore, information derived from these studies will 
provide the basis for future studies using human cell 
cultures. 
2. MATERIALS AND METHODS 
2.1. Tissues ctnd cell cultures 
Cerebral cortex was dissected from newborn. 4-day-old or adult rats 
sacrificed by decapitation. The meninges were peeled off the cortex 
~md rinsed before use ['or RNA and protein analysis. The cerebral 
cortex was then frozen for further studies or used for cell cultures 
which were carried out according to McCarthy and DeVeillis [43] with 
some modifications (R. Miller. CWRU, Cleveland, OH). The newborn 
rat cerebral cortex was minced and cells were dissociated in 0.05% 
trypsin type II! (Sigma. St. Louis. MO) for 20 min at 37°C followed 
by trituration in 4 Kunitz unit/ml DNasel (Sigma). Cells were plated 
in 10% FBS/DMEM (Hyclone Lab. Logan, Utah) on poly-L-lysine- 
coated Falcon 3024 or 3045 flasks. 
Astrocytes were obtained by shaking the flasks vigorously 4-6 h 
after plating. The astroeytes adhere strongly to the flask and all other 
cell types are removed in the medium. Neurons were recovered in the 
medium after very gentle shaking of the cortical cultures 4-6 h after 
plating and were replated on poly-L-lysine-covered flasks. Microglial 
cells were detached by shaking cortical cultures at 10 days in vitro 
(DIV) on an orbital shaker for I h at 180 rpm [44]. The medium 
containing the microglial cells was transferred to poly-L-lysine-coated 
flasks for I h. Microglial cells adhere to the flask during this time and 
other cell types and debris can be removed with the medium. 
2.2. C'luo'actcrizathm ~f'the cell cultures 
The purity of astroglial and neuronal cultures was determined by 
immunofluorescence with polyclonal antibodies to glial fibrilltlry 
acidic protein (GFAP) [45] and the monoclonal antibody 1.2.1 to 
neurofilament proteins [46]. respectively, following fixation in 2% pa- 
raformaldehyde, Microglial cultures were assessed for their ability to 
ingest AcLDL-Dil (acetylated low density lipoprotein labeled wi~b 
l,l'-dioctadccyl l-l-3.3,3'.3'-tetramethyl indocarbocyanine p rchlo- 
rate [47]) according to the manufacturer's instructions (Biomedical 
Tech. Inc., MA). Contarni.~ating fibroblasts were identified with anti- 
bodies to rat fibronectin (Calbiochem Corp., LaJolla. CA). Oligoden- 
droglia were distinguished by their morphological ppearance [48] and 
their lack of immunorcactivity with the above described antibodies. 
Immunofluorescence and phase contrast were observed with a Leitz 
Dialux microscope equipped with epifluorcscence illumination, 
2.3. RNA anul)'sis 
Total cellular RNA was extracted as described by Chomczynski avid 
Sacchi [49]. RNA yield was determined by spectrophotometry [50]. 
Northern blot analysis was carried out using formaldehyde asa dena- 
turant [51]: the RNA was transferred to nitrocellulose and hybridized 
in formamide at 42°C [52]. The APP probe was the 420 bp Pvull/ 
EcoRl frtlgmenl of APP~.~ eDNA labeled by random priming [53] at 
1.0 1.5 x 10 '~ cpm/#g DNA. The/3,actin probe was a 300 bp fragment 
obtained by PCR amplific:,tion of reverse transcribed rat brain 
mRNA. 
Slot blots were carried out according to Cheley and Anderson [54]. 
Each slot blot was probed with the 1.056 kb EcoRl fragment ot'APPc,.~ 
or ]3-actin eDNA probes as described above. The RNA on slot blot 
autoradiograms was quantitated by densitometric scanning with the 
LKB Ultroscan XL. The leve! of APP mRNA was expressed as peak 
area of APP mRNA/peak area aetin mRNA for 1 /~g of total RNA 
and the results from each sample expressed relative to that of the 
cortex. In order to assure that fl-actin was appropriate to normalize 
the amount of APP mRNA, all slot blots were reprobed with a 6 S 
rRNA PCR-amplified probe. The levels of 6 S rRNA paralleled those 
offl-actin. 
Ribonuclease protection assays (RPA) were carried out using an 
RNA probe transcribed from pBluescript KS- carrying a fragment of 
human APP77 o eDNA (nucteotides 642-1089; numbering according to 
Kitaguchi eta l .  [55]). The RNA probe protects 440 nucleotides in 
APPvvt~, 386 nucleotides in APPT.~t (and APP~),  223 nucleotides in 
APP~,~s and two fragments of 223 and 56 nucleotides in APPTI4. Neither 
APPvl4 mRNA. which has been observed at very low levels in rat brain 
[1 I] nor APP,6) mRNA which was not detcctable in the newborn rat 
cortex by PCR (results not shown) are likely to be represented in the 
RPA results: therefore the three bands observed are probably due to 
APP6~s. APP751 and APP77t~ mRNAs, although the 2.7 kb APP mRNA 
which contains the KPI sequence could be part of APPTs~ or APP770 
mRNA. The RPA was carried out with the RPA-ribonuclease protec- 
tion assay kit (Ambion Inc.. Austin. TX) according to the manufactur- 
er's instructions. The ratio of each APP mRNA was determined by 
densitometric scanning of the autoradiograms and corrections were 
made to account for the r-'P-dCTP content of the probe. The r sults 
are expressed as peak area of a specific mRNA/total peak area for all 
three APP mRNAs. Statistical difference between two samples was 
evaluated by Student's 2-tailed unpaired r-test. 
2.4. Protein amd.vsis 
Cellul;Ir proteins were obtained by homogenization f cells in 0.1 
M Tris-HCI. pH 7.4, and centrifugation at 16 000xg for30 rain at 4°C. 
The supernatant which did not contain any APP immunoreactivity 
was discarded. The pellet was solubilized by boiling for 2 min in 
cleetrophoresis sample buffer (0.25 M Tris-HCl, pH 8.6. 1.92 M gly- 
cine. 0.5% SDS. 2% mercaptoethanol) and protein concentration was 
determined by the BCA assay [56]. Proteins were resolved by poly- 
aerylamide gel electrophoresis, transferred to nitrocellulose and the 
membranes blocked with 20% fetal bovine serum (FBS)in TBST (10 
mM Trls-HCl, pH 8.0. 150 mM NaCI, 0.01% Tween 20). The immu- 
noblot was probed with anti-C7 rabbit serum (generously provided by 
D. Selkoe) made to a synthetic peptide corresponding to the C-ter- 
minal region of APP [13] amino acids 732-751 according to the 
numbering of Ponte et al. [9]. Immunorcactive bands were detected 
with an alkaline phosphatase-conjugated goat anti-rabbit IgG 
(Promega protoBlot-Western system. Madison. Wl) using BCIP/NBT 
substrates or with the PhotoBIot system (Gibco/BRL, Gailhersburg, 
MD). As a control for antibody speciticity, imnaunoblots were in- 
cubated with anti-C7 in the presence of I/,tg of the synthetic peptide 
(a kind gift from T, Kunishita and S. Younkin, CWRU). 
3. RESULTS 
3.1. Characterization of the prhnctrt, cell cultures 
Astro¢3'tes. Astroglial cells isolated from neonatal r~tt 
cerebral cortex (Fig. IA) extended long processes dur- 
ing the first 2 DIV [48] and were GFAP-positive (+). 
These processes flattened thereafter and by 4 DIV, the 
cells had a fibroblast-like appearance and proliferated 
actively as expected of type 1 astrocytes. At 4 and 21 
DIV. over 95% of the cells were GFAP(+). 
Neurons. Within 2 DIV. cortical neurons established 
long neuritic processes and over 95% of the cells were 
immunostained with an antibody to neurolilamcnts 
(Fig. 1B). Some of the other cells were GFAP(+) astro- 
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Vig. 1. Pr imary cultures of cortical astrocytes, neurons and microglia. (A) Astrocytes 4 DIV and (B) neurons 2 DIV were immunosta ined with an 
ant iserum to GFAP and monoclonal  ant ibody to neurofi lamenls, respectively• (C) Microglia cultures I I D IV were incubated with AcLDL-D i l  
fo r  4 h, Immunoreact iv i ty  was detected in 95% of the ce l l s  in astrocyte and neuron cultures while 98% of  the  ce l l s  in microglial cultures ingested 
AcLDL-D I I .  
glia (results not shown) ,  while a few had the appearance 
o f  o l igodendrogl ia  [48]. 
Microgl ia. Over  98% o f  the cells iselated from cortical 
cultures at 10-30 D IV  had the abil ity to phagocyt ize  
AcLDL-D i I  (Fig. IC). Most cells had the amoebo id  
appearance described for microgl ial  cells upon initial 
isohtt ion and, as expected o f  microgl ia l  cells, dif feren- 
t iated into process-bear ing cells after a few days in cul-  
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Fig. 2. Northern blot analysis of newborn rat cerebral cortex, menin- 
ges, and primary cultures of astrocytes, neurons and mieroglia. (A) 
Total cellular RNA (20/~g/lane) was probed for APP and fl-actin 
mRNA content. (B) Astrocyte total cellular RNA (30/tg) was probed 
with a KPl-encoding eDNA. Size markers in kb (Pharmacia RNA 
ladder) are indicated on the right. 
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Fig. 3. Quantitalive analysis of total APP mRNA by slot blot analysis 
in newborn rat cerebral cortex, meninges, primary cultures ofastrocy- 
tes, neurons and microglia. Total APP mRNA levels from astrocytes 
(4 DIV), microglia (11 DIV), neurons (4 DIV) and meninges were 
expressed relative to the normalized level of newborn rat cerebral 
cortex APP mRNA. mRNA levels were significantly different when 
compared to each other (P<0.003) except for those of astrocytes and 
microglia, which were similar (P>0.5). 
ture [44]. The other 2% of cells resembled oligoden- 
drocytes [48] or were GFAP(+) (results not shown). 
3.2. Total APP mRNA is most abwldant in menhlges 
and in cortical neuronal cultures 
Total APP mRNA was detected as a 3.2-3.4 kb band 
in cortex, meninges, and cortical microglia, astrocytes 
and neiarons (Fig. 2A). An additional mRNA of 2.7 kb 
which contains the KPI sequence (Fig. 2B) was relative- 
ly abundant in glial cells and highly expressed in me- 
ninges. The difference in size with the 3.2 kb mRNA 
excludes the possibility that this mRNA is one of the 
major known forms of APP mRNA. In addition, an 
APP mRNA of 2 kb was detected in meninges. Relative 
to cortical levels, APP mRNA quantitated by slot blot 
analysis, was most abundant in the meninges (4.5-fold), 
and neurons of 1-4 DIV (l.4-fold). In contrast, astrocy- 
tes at 4 DIV (0.26-fold) and microglial cells from 10 
DIV cortical cultures (0.24-fold) had lower levels of 
APP mRNA (Fig. 3). 
3.3. Differential expression of APP transcripts is cell 
specific and it~luenced by cell culture conditions 
The relative abundance of APP69.~, APP751 and APP770 
mRNA assessed by RPA revealed alternative splicing 
patterns • pecific to neurons and glial cells (Fig. 4A). 
Newborn rat cerebral cortex (0 DIV) which contains 
mostly neurons [57] and neuronal cultures expressed 
APP69 ~ mRNA predominantly whereas meninges, 
astrocytes and microglia contained mostly KPl-con- 
taining APP mRNAs. Quantitation of the RPA results 
showed that cortical neurons (2 DIV) expressed APP6~,~ 
mRNA as 93% of total APP mRNA as well as low levels 
of APPT.~I mRNA (7%) while APP77, mRN~ was barely 
detectable (<1%) (Table I). Glial cell APP mRNA ex- 
pression differed significantly from that of neurons 
(P<0.02). Both astrocytes at 2-4 DIV and microglia at 
10-30 DIV contained high levels of APP751 mRNA 
(50% of total APP mRNA) and lower levels of APP695 
(30%) and APP770 mRNA (20%). The pattern of APP 
mRNA expression in astrocytes and microglia was al- 
most identical to that of meninges in newborn rat brain. 
It was interesting to note that within 4 days of culture. 
the pattern of APP mRNA expression changed in corti- 
cal cultures from predominant APP695 mRNA to higher 
KPl-containing mRNA expression (Fig. 4A and Table 
I). Quantitative analysis of RPAs revealed that APP695 
mRNA represented ~78% of total APP mRNA in neona- 
tal rat cerebral cortex whereas APP75~ and APP770 
mRNA were 15 and 7% respectively (Table I). By 4 
DIV, the APP6~5 mRNA decreased to 36% of total APP 
mRNA with a concomitant increase in APP75 ~ mRNA 
(51%) (P<0.01). At 6 DIV. APP6,j~ mRNA decreased 
further to 11% and remained stable until 21 DIV. Four- 
day-old rat cortex (0 DIV) retained high levels of APP695 
mRNA which also switched to high levels of KPI-con- 
taining APP mRNA after 3 DIV (Fig. 4B). Further- 
more, adult rat brain also retained high levels of APP¢,95 
mRNA. These results indicated that either a splicing 
switch occurs in the cerebral cortex with time in culture 
or the cell population of cultured cerebral cortex differs 
significantly from that of developing cerebral cortex. 
Differential APP mRNA expression changed signifi- 
cantly in astrocytes maintained in culture for 20 days or 
longer (Table I), The level of APP~,,~.~ mRNA decreased 
from 36 to 6% with a reciprocal increase in APP770 
mRNA from 14% to 49% (P<0.005) whereas the reht- 
tive amount cfAPPT.~ mRNA did not change with time 
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Fig. 4. Differential APP mRNA expression in rat cerebral cortex and 
primary cultures ofcortical astrocytes, microglia nd neurons. (A) The 
protected APP fragments resulting from ribonuclease protection as- 
says (5-10/~g total RNA) were separated on denaturant 5% polyacryl- 
amide gels. High levels of APP~ mRNA were detected exclusively in 
neurons and cerebral cortex (0 DIV) whereas high levels of KPI- 
containing APP mRNA were observed in meninges, microglia and 
astracytes as well as in whole cortical cultures of 4 DIV, Intact probe 
(Yeast RNA - RNase) is almost all digested with RNase treatment 
(Yeast RNA + RNase). High levels of APP~9~ mRNA in adult and 
4-day-old rat cerebral cortex but higher levels of KPl,containing 
mRNAs in 4-day-old rat cerebral cortex cultured 3 days. Note that 
different amounts of RNA and exposure times were used to facilitate 
detection. 
in culture. Over 95% of the cells in astrocytic cultures 
remained GFAP(+) at 21 DIV, eliminating the possibil- 
ity that the switch in APP gene expression is the result 
of a changing cell population with time in culture. A 
similar shift in APP mRNA expression was also ob- 
served in neurons between 3 and 4 DIV (Table I). How- 
ever, it was not established whether the switch is an 
intrinsic feature of neuronal cells maintained in culture 
or whether it is due to a change in cell population. 
3.4. The type of cellular APP represents differential 
APP mRNA expression in each tissue and cell type 
but the relative amount of protein does not parallel 
APP mRNA levels 
Immunoblots of cellular proteins with antibodies to 
the C-terminal fragment of APP revealed that the pat- 
tern of APP proteins paralled that of APP mRNA (Fig. 
5A). Competition expeirments eliminated all immune- 
reactive bands except wo (Fig. 5B). Rat neonatal cortex 
displayed an intense APP band of  approximately I10 
kDa which is likely to be APP695, and a less intense 
slightly higher mol.wt, band similar to a previous report 
[58]. Two additional higher mol.wt, bands were detected 
in the meninges and are probably the KPI-containing 
forms of APP. Neuronal APP proteins were similar to 
those of  cortex, with a major APP band migrating at 
110 kDa. Astrocytes appeared to have multiple APP 
species ranging from a scarcely expressed species of  I 10 
kDa to 4 more abundant forms above 1 I0 kDa. Surpris- 
ingly, the steady-state level of APP was lower in menin- 
ges although these contained the highest level of APP 
mRNA, and was barely detectable in microglial cells 
which contain as much APP mRNA as astrocytes. 
Table I 
Differential APP mRNA expression in newborn rat cerebral cortex, meninges and primary cultures of cerebral cortex, astrocytes, neurons and 
microglia 
Sample DIV n APP695 APPT~I APP77o 
Cortex 0 4 0.78 + 0.15 0.15 + 0.10 0,07+ 0,06 
2 3 0.81 + 0.02 0.16 + 0.01 0.03 +0.01 
4 3 0.36 4._ 0.09 0.51 + 0.08 0.13 +_ 0.06 
6 2 0.11, 0.18 0,60, 0.66 0.29, 0.16 
21 3 0.11 + 0.00 0.78 4. 0.04 0.11 + 0.04 
Meninges 
Astrocyte 
Neuron 
0 7 0.30 + 0.07 0.49 + 0.07 0.22 ± 0.04 
2 I 0.36 0.50 0.14 
4 6 0.29 + 0.09 0.50 + 0.I0 0.21 ± 0.11 
>21 5 0.06 + 0.04 0.45 + 0.03 0.49 + 0.03 
2 3 0.93 + 0.07 0.07 "+" 0.06 0.01 ± 0.01 
3 2 0.93, 0.83 0.06, 0.12 ND 
4 4 0.63 + 0.07 0.28 + 0.06 " 08 ± 0,07 
Microglia 10-30 3 0.24 _+ 0.16 0,61 _+ 0.15 0.15 _+ 0.09 
Thc proportion ofeach APP rnRNA in specific ells and tissues was determined by densitomctric s anning of the RPAs. Values for each APP mRNA 
transcript arc cxpresscd as a fraction of the normalized sum of all three APP mRNAs. Each value rcprcsents the mean of n samples + standard 
deviation. ND = not determined. 
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F ig .  5. Western blot analysis of cellular APP proteins from newborn 
rat cerebral cortex, meninges and primary cortical cultures of astrocy- 
tes. neurons and microglia. (A) Cellular proteins (20 pg/lane) were 
resolved on 10% polyacrylamide g ls. lmmunoblots with anti-C7 anti- 
bodies detected fulllength APP species in newborn rat brain cortex 
(0 DIV), meninges (0DIV). astrocytes (4 DIV) and neurons (2 DIV) 
but not in microglial cells (10 DIV). In addition, two smaller immuno- 
reactive APP proteins of 16 and 26 kDa were detected in cerebral 
cortex and meninges. Exce at for the faint presence of the 26 kDa band 
in neurons, these were not :letected in any of the primary cell cultures. 
(B) Immunoreactivity of anti-C7 antibodies with all these proteins was 
specifically competed with C-peptide with the exception of a 67 kDa 
band. 
3.5. Low moL zvt. C-termhlal fragments are not detected 
h~ the prhnat3, cell cuhures 
In addition to the full length APP forms, the anti-C7 
antibody specifically detected 2 lower mol.wt, species of 
26 kDa and 16 kDa in the cortex and meninges. The 26 
kDa protein was weakly detected in neurons but not in 
glial cultures whereas the 16 kDa protein was not ob- 
served in any of  the primary cell cultures (Fig. 5). These 
immunoreactive proteins are likely to be C-terminal 
fragments of APP. 
4. DISCUSSION 
APP gene expression was investigated in newborn rat 
cerebral cortex, meninges and primary cultures of corti- 
cal neurons, astrocytes and microglia to gain insight 
into the possible contribution of  individual CNS cells in 
flAP deposition. The highest level of APP mRNA was 
found in the meninges. High levels o fAPP  mRNA were 
detected in neurons in agreement with most in situ hy- 
bridization studies [17-24]. Microglia and astrocytes 
contained an equivalent amount of APP mRNA which 
was lower than that of neurons, The higher steady-state 
level of APP mRNA in neurons compared to glial cells 
indicates ccll-specific transcriptional regulation of APP 
gene expression which may be relevant o the functional 
role of APP in these different cell types. 
The high levels of APP mRNA in meninges and neu- 
rons may be relevant o the deposition of amyloid in 
meningeal and cerebral cortical vessels as well as within 
the parenchyma of  the cerebral cortex in AD. In heredi- 
tary cerebral hemorrhage with amyloidosis of  Dutch 
type, a disease characterized by extensive flAP deposits 
in leptomeningeal nd cortical vessel walls, a point mu- 
tation in the flAP sequence has been identified and sug- 
gested to be the cause of  amyloid deposition in this 
disease [59]. Another mutation in the APPgene has been 
identified in familial AD [60-62]. This mutation dis- 
rupts a stem loop structure of  APP mRNA that may 
impair translational regulation leading to over-expres- 
sion of the APP and abnormal evels of f lAP [63] as 
observed in Down's syndrome patients. Therefore, high 
levels o fAPP  mRNA in neurons and meninges coupled 
with abnormally high translation of  the mutant APP 
mRNA could lead to substantial levels of f lAP deposi- 
tion if over-expression is indeed a primary cause of 
abnormal deposition of  flAP. 
We observed that not only the level of total APP 
mRNA but also the ratios of  the various APP mRNA 
species were different in neurons and glial cells indicat- 
ing cell-specific post-transcriptional regulation at the 
splicing level. In newborn rats, neurons expressed high 
levels of  APP695 mRNA whereas microglia and astrocy- 
tes expressed higher levels of  KPI-containing APP 
mRNA. This pattern of APP mRNA expression was 
comparable to that reported for the mouse [39], al- 
though we detected significant levels of APP695 mRNA 
in rat astrocytes at 2-4 DIV and microglia cultures. It 
has previously been reported that type I astrocyte cul- 
tures do not express KPI-containing forms of  APP [40]. 
In our culture system, the RNase protection assay and 
Northern blots with a probe containing only the KPI- 
encoding APP  cDNA sequence, clearly revealed a high 
level of KPI-containing APP mRNA in astrocyte pri- 
mary cultures. 
The change in differential APP mRNA expression in 
astrocytes with increasing time in culture is indicative 
of  a switch in alternative APP mRNA splicing. Whether 
this switch in splicing occurs in aging astrocytes in vivo 
or is the result of the culture conditions remains to be 
determined. Higher proportions of APP751 mRNA ~tnd 
APP770 mRNA have been detected in AD cases compar- 
ed with normal controls [37,64] and in rats with spatial 
memory deficits [65] not unlike that observed in our 
cultures. The switch in splicing was also observed in 
cerebral cortical cells maintained for some time in cul- 
ture. However, intact cerebral cortex of adult rats re- 
tained high expression of APP~,~.~ mRNA. It is possible 
that the cell population that evolves in cultured cerebral 
cortex differs from that of developing cerebral cortex. 
There were also remarkable discrepancies in some 
cell types between the amount of  APP mRNA and th,'tt 
176 
Volume 292, number 1.2 FEBS LETTERS November  1991 
of APP isoforms. Microglia, which displayed APP 
mRNA levels comparable to that of astrocytes, con- 
tained barely detectable amounts of APP which were 
instead relatively abundant in astrocytes. Meninges, 
which exhibited the highest level of total APP mRNA, 
contained less APP than neurons and astrocytes. These 
results are consistent with either negative translational 
regulation of APP gene expression or enhanced turn- 
over of APP in microglial cells and meninges, whereas 
increased translational efficiency or lower turnover of 
APPs may explain the relatively abundant APPs in 
astrocytes. A high turnover ate of APPs would support 
the postulate that microglia are producers as well as 
processors of,BA P peptide [25]. Further studies, such as 
pulse chase experiments, will determine which of these 
mechanisms regulates the steady-state l vels of APP 
proteins in these cells. 
The low levels or absence of immunoreactive p ptides 
of 26 and 16 kDa in neuronal and astroglial cultures is 
intriguing. These proteins are most likely C-terminal 
fragments resulting from proteolytic processing of 
APPs. Similar C-terminal fragments of APP have been 
detected in rat brain membranes [66], APP-transfected 
293 cells [67] and PC12 cells [68]. The absence of these 
fragments in primary culture systems raises the possibil- 
ity that post-translational processing of APP or tur- 
nover of APP C-terminal fragments changes in culture 
conditions. 
In addition to the normally observed 3.2 kb mRNA, 
meninges expressed APP mRNAs of 2.7 kb and 2.0 kb. 
Astrocytes and microglial cells also contained relatively 
abundant levels of the 2.7 kb APP mRNA species. An 
APP mRNA ~pecie,~ of similar size was detected pre- 
viously in rat tissue [69]. We show that the 2.7 kb APP 
mRNA contains the KPI domain and preliminary re- 
suits indicate that the flAP region is also present. Fur- 
ther studies are underway to determine the exact nature 
of this form of APP mRNA. The 2 kb band in meninges 
is probably APP~,3 mRNA [12]. 
In conclusion, our results suggest hat regulation of 
APP gene expression is highly complex and under tight 
control in specific cell types of the CNS. Although the 
APP gene expression in short-term cultures reflects the 
in vivo situation, long-term cell cultures appear to 
change the pattern of alternatively spliced APP mRNAs 
and possibly affect post-translational processing of APP 
as well. Therefore, it is reasonable to believe that disrup- 
tions of the CNS environment will influence the regula- 
tion of APP gene expression in neurons, microglia and 
astrocytes and that any of these cells could be responsi- 
ble for flAP deposition under appropriate conditions. 
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